COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysis

IMPORTANCE: Patients who are immunocompromised have increased risk for morbidity and mortality associated with coronavirus disease 2019 (COVID-19) because they less frequently mount antibody responses to vaccines. Although neutralizing anti-spike monoclonal-antibody treatment has been widely used to...

Descripción completa

Detalles Bibliográficos
Autores principales: Senefeld, Jonathon W., Franchini, Massimo, Mengoli, Carlo, Cruciani, Mario, Zani, Matteo, Gorman, Ellen K., Focosi, Daniele, Casadevall, Arturo, Joyner, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857047/
https://www.ncbi.nlm.nih.gov/pubmed/36633846
http://dx.doi.org/10.1001/jamanetworkopen.2022.50647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857047/
https://www.ncbi.nlm.nih.gov/pubmed/36633846
http://dx.doi.org/10.1001/jamanetworkopen.2022.50647

Ejemplares similares